Panel predicts whether rare leukemia will respond to treatment
Monday, March 30, 2015 - 20:30
in Health & Medicine
Patients with chronic myelomonocytic leukemia have limited treatment options, and those that exist are effective only in fewer than half of patients. Now, a new study identifies a panel of genetic markers that predicted which tumor samples would likely respond to treatment.